Printer Friendly
The Free Library
6,672,335 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

University of Tokyo, NTT DATA Co-develop Prototype for Tailored Medication Support System.


Tokyo, Japan, Oct 25, 2005 - (JCNN JCNN Japan Corporate News Network ) - NTT NTT Nippon Telegraph and Telephone Corporation
NTT New Technology Telescope
NTT National Technology Transfer, Inc
NTT Name That Tune (TV game show)
NTT National Tree Trust
NTT Number Theoretic Transform
 DATA announced on October 24 that it has developed a prototype Tailored Medication Support System (provisional name), a support system for doctors when they make a decision on medication.

The prototype securely stores information on patient genotypes and compares them with drug evidence to indicate an optimal choice and dosage of drugs according to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 a genotype of each patient.

The two partners expect that the prototype will pave the way for the commercialization of tailored medication. Going forward, they will make a test installation at a specific hospital and make improvements to the current system. Further, they will upgrade the system for practical use, so that it will be able to use information on actual drugs and patients by the end of fiscal 2006.

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Oct 28, 2005
Words:147
Previous Article:Taisho Pharmaceutical Begins Marketing Glucocare Powder, Specified Health Food for Inhibiting Rise in Blood Sugar Level.
Next Article:Sanwa Kagaku Kenkyusho Introduces Safety-engineered Blood Sampling Device and Disposable Needle.



Related Articles
Toppan Printing, Shimadzu, Riken Jointly Develop Fully Automated All-in-one SNPs Analysis System.
NTT Data Acquires Majority Share of The Revere Group for System Integration Business Expansion.
NTT and SEGA Start Joint Experiment on Object Recognition Technology Enabling Combination of 2D/3D Objects in Real World and Services on the Internet.
NTT DoCoMo Announces HSDPA Handset Prototypes.
NTT Tests New Dimension in US-Japan Telepresence and Telemedicine in Fetal Care Management by Linking Research and Education Networks.
NTT DoCoMo Develops 3G FOMA SIMPURE Series of Basic Handsets - Compatible with WORLD WING Global Roaming Service.
Mizuho Bank, UC Card, NTT DoCoMo Sign Comprehensive Agreement.
Tokyo Women's Medical University, Order-Made Souyaku, NTT Data Jointly Undertake Research on Tailor-made Treatment for Rheumatoid Arthritis.
NTT DoCoMo and Aquafairy to Develop Micro Polymer Electrolyte Fuel Cell for FOMA Handsets.
NEC Supplies HSDPA Infrastructure Systems to NTT DoCoMo.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles